Several healthcare ETFs hold major pharmaceutical companies like Eli Lilly, J&J, and Novo Nordisk as top 3 positions, leading to competition for investor capital.
1 report, 1 independent
Updated Jun 18
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Several healthcare ETFs hold major pharmaceutical companies like Eli Lilly, J&J, and Novo Nordisk as top 3 positions, leading to competition for investor capital.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Reports on the top holdings of various healthcare and biotech ETFs, listing major pharmaceutical companies like Eli Lilly, Amgen, and Johnson & Johnson.Sub-event
Healthcare ETFs are competing for investor capital by holding top positions in major pharmaceutical companies.1 source
Keep exploring
The entities involved
-
Eli Lilly and Company
American pharmaceutical company
-
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
-
Novo Nordisk
Danish pharmaceutical company
Related events
- Eli Lilly and Novo Nordisk are competing for market share in the weight loss drug sector.
- Eli Lilly captured market share from Novo Nordisk in the weight loss drug sector.
- Morgan Stanley estimates market growth for GLP-1 drugs, noting competition between Eli Lilly and Novo Nordisk.
- Novo Nordisk operates in Europe, North America, the Middle East, and mainland China, while MarketBeat covers both Novo Nordisk and Eli Lilly.
- Investors are surveying market sentiment while ETFs hold major companies in both the utility and healthcare sectors.